158 related articles for article (PubMed ID: 16753873)
1. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
[TBL] [Abstract][Full Text] [Related]
3. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
4. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
Seftel MD; Bruyere H; Copland M; Hogge DE; Horsman DE; Nantel SH; Shepherd JD; Lavoie JC; Le A; Sutherland HJ; Toze CL; Nevill TJ
Eur J Haematol; 2002 Oct; 69(4):193-9. PubMed ID: 12431237
[TBL] [Abstract][Full Text] [Related]
5. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
[TBL] [Abstract][Full Text] [Related]
6. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
[TBL] [Abstract][Full Text] [Related]
7. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
8. The analysis of the risks for the development of tumour lysis syndrome in children.
Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of tumor lysis syndrome in 380 cases of acute leukemia].
Zhang Q; Liu KQ; Liu BC; Zhou CL; Li W; Lin D; Wang Y; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):61-4. PubMed ID: 25687047
[TBL] [Abstract][Full Text] [Related]
10. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
[TBL] [Abstract][Full Text] [Related]
12. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
Kedar A; Grow W; Neiberger RE
Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
[TBL] [Abstract][Full Text] [Related]
13. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
Kikuchi T; Miyata A; Fujii S; Kikuchi T
Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
Gartenberg A; Winkel M; Leonard N
Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
[TBL] [Abstract][Full Text] [Related]
16. Tumor Lysis Syndrome (TLS) following intrathecal chemotherapy in a child with acute myelogenous leukemia (AML).
Glasser CL
Leuk Res Rep; 2017; 8():19-20. PubMed ID: 29159035
[TBL] [Abstract][Full Text] [Related]
17. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
18. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.
Mattiuzzi GN; Kantarjian H; O'Brien S; Kontoyiannis DP; Giles F; Zhou X; Lim J; Bekele BN; Faderl S; Cortes J; Pierce S; Leitz GJ; Raad I; Estey E
Cancer; 2004 Feb; 100(3):568-73. PubMed ID: 14745874
[TBL] [Abstract][Full Text] [Related]
19. Tumor lysis syndrome: risk factors, diagnosis, and management.
Burns RA; Topoz I; Reynolds SL
Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
[TBL] [Abstract][Full Text] [Related]
20. Our experience with tumor lysis syndrome treatment.
Sirelkhatim A; Sejnova D; Puskacova J; Subova Z; Kaiserova E
Bratisl Lek Listy; 2008; 109(12):560-3. PubMed ID: 19348378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]